Picture of Oncoinvent ASA logo

ONCIN Oncoinvent ASA Cashflow Statement

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Oncoinvent ASA, fiscal year end - December 31st, millions except per share.

2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M
Source:ARSARSPRESS
Standards:
IFRS
IFRS
Status:
fx
Preliminary
fx
Preliminary
FinalFinalFinal
Net Income/Starting Line-106-144-140
Depreciation
Non-Cash Items-4.44-4.41-1.75
Other Non-Cash Items
Changes in Working Capital13.5-1.3439.4
Change in Accounts Receivable
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-89.2-138-87.9
Capital Expenditures-3.98-26.8-1.8
Purchase of Fixed Assets
Other Investing Cash Flow Items04.412.11
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-3.98-22.40.305
Financing Cash Flow Items-0.094-0.342-12.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2.93-3.37191
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-96.1-164104